Clinical Trial Results TV
Main Menu
Home Page
Member Area
Browse all videos
Series
Duke Clinical Medicine
Cath Lab
ACS
Endocrinology
Gastroenterology
Nephrology
Heart Failure
SCAI TV
Categories
Antiplatelets
Antithrombins
Aortic Disease
Behind The Science
Biomarkers
CABG
CHF
CT Angio
Cardiac MRI
Clinical Cases
Congenital
DVT / PE
Diabetes
ECG, EKG, Holter
ECHO
EP
ETT / Nuclear Imaging
Fellows' Training
Genetics
HTN
Health economics QOL
Hospital Administration
International
Lipid Lowering
Lower extremity Dz
Lytics
Non Atherosclerotic Arterial Dz
PAD
PCI / Devices
Pathophysiology
Patient Education
Pericardium
Private Practice
Public Health
Pulm. Art. HTN
ST Elevation MI
Stable Angina
Stem Cell Tx
Stroke
Trial / Study
UA / NSTEMI
Valvular Heart Dz
Vlogs
Womens' Health
Antithrombins: 21 submissions (showing 16 to 21)
|
Page 1
|
Page 2
|
REPLACE-II and ACUITY: Transitioning Between Antithrombins in the Cath Lab by C. Michael Gibson, MD
Dr. C. Michael Gibson
Results from ANTHEM: A Phase 2 Heparin Replacement Trial Evaluating rNAPc2 in ACS
Dr. Robert Giugliano
Dr. Gibson Discusses the TRA-PCI trial
Dr. C. Michael Gibson
Coronary Revascularization in Diabetic Patients - Optimizing Outcomes in 2007
Dr. David J. Cohen
Dr. Gregg Stone Presents the ACUITY 1 Year Results
Dr. Gregg Stone
Drs. Rao and Tu review pharmacologic therapies for ACS & how bleeding risk is shaping the discussion
Dr. Thomas Tu, Dr. Sunil Rao
clinicaltrialresults.org